Prognostic value of DNA analysis of prostate adenocarcinoma: correlation to clinicopathologic predictors.
The ability to accurately predict tumor behavior and patient survival is a problem in managing patients with prostate cancer. DNA ploidy provides important information for the evaluation of the prognosis of prostate cancer. The aim of this study was to investigate the DNA ploidy in imprints from prostate adenocarcinomas in a group of 70 patients in relation to Gleason score, tumor differentiation, stage and PSA serum levels. The DNA content was studied in Feulgen-stained imprint smears through the image analysis technique using a SAMBA 2005 Image analyzer. According to our measurements, a strong correlation was observed between DNA ploidy status and tumor differentiation (p<0.001). A statistically significant difference was found between DNA aneuploidy and increased pretreatment PSA serum levels (>4 ng/ml) (p<0.001), as well as between ploidy pattern and stage of the disease (p<0.001). Our results conclude that DNA ploidy status appears to be an additional marker in the field of prognosis of prostatic adenocarcinoma and could provide useful information on the potential behavior of prostate cancer.
Bantis
A
A
Pathology Laboratory, Cytology Department Medical School, University Hospital Alexandroupolis, Athens, Greece.
Gonidi
M
M
Athanassiades
P
P
Tsolos
Ch
Ch
Liossi
A
A
Aggelonidou
E
E
Athanassiadou
A M
AM
Petrakakou
E
E
Athanassiadou
P
P
D000230:Adenocarcinoma / Q000175:diagnosis* / Q000235:genetics* / Q000401:mortality; D000368:Aged; D000782:Aneuploidy; D002454:Cell Differentiation; D004247:DNA / Q000378:metabolism*; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008297:Male; D008875:Middle Aged; D011003:Ploidies; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000235:genetics* / Q000401:mortality; D012044:Regression Analysis; D013997:Time Factors; D016896:Treatment Outcome
D004247:DNA